SPC426
Samsetning af foslevódópa og foskarbídópa, hvort á öllum formum sem vernduð eru af grunneinkaleyfinu
Status:
UmsóknApplication date:
18.4.2023Application published:
15.5.2023
Max expiry date:
20.10.2035Medicine name:
ProduodopaMedicine for children:
No
Timeline
Today
18.4.2023Application
15.5.2023Publication
20.10.2035Expires
Marketing license
IS authorization number:
IS/1/22/069/01Date:
27.10.2022
Foreign authorization number:
141371Date:
25.8.2022
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, North Chicago US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3209302